Across TCGA pan-cancer cohorts, C7orf65 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated C7orf65 data layer compared with 22 for mass-spec protein.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher C7orf65 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated C7orf65 expression acts as an unfavorable survival marker.

READ and LUAD are the cancer types where C7orf65 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Median	All	0.166	0.830	<.001	27	view →
LUAD	DFS	Median	All	0.213	0.676	.012	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: C7orf65 tumor-vs-normal RNA expression · all C7orf65 data types